Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: Results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010

Diagnostic Microbiology and Infectious Disease

Volumn 80, Issue 2, 2014, Pages 162-167

[No Author Info available]

Author keywords

Community associated MRSA; Hospital associated MRSA; Minimum inhibitory concentrations; SCCmec; Vancomycin

Indexed keywords

CEFOXITIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ACCESSORY GENE REGULATOR; AGAR DILUTION; AGR GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BASE PAIRING; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRU GENE; GENETIC POLYMORPHISM; GEOMETRY; HEALTH SURVEY; HOSPITAL ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; HUMAN; IN VITRO STUDY; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MEC ASSOCIATED HYPERVARIABLE REGION; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCCMEC GENE; STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC; TREND STUDY; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; MULTICENTER STUDY; STAPHYLOCOCCAL INFECTIONS; TAIWAN;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; GENES, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; TAIWAN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84929502983     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.06.007     Document Type: Article

References (43)

1. Alós J.I., García-Cañas A., García-Hierro P., Rodríguez-Salvanés F. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage. J Antimicrob Chemother 2008, 62:773-775.
2. Boyle-Vavra S., Ereshefsky B., Wang C.C., Daum R.S. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol 2005, 43:4719-4730.
3. Chen C.J., Huang Y.C. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. J Microbiol Immunol Infect 2005, 38:376-382.
4. Chen C.J., Hsueh P.R., Su L.H., Chiu C.H., Lin T.Y., Huang Y.C. Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infect Dis 2009, 65:199-201.
5. Chen Y.H., Lu P.L., Huang C.H., Liao C.H., Lu C.T., Chuang Y.C., et al. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010. Antimicrob Agents Chemother 2012, 56:1452-1457.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 19th informational supplement (M100-S19) 2009, CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial disk susceptibility tests. Approved standard (M02-A10) 2009, CLSI, Wayne, PA.
8. DeLeo F.R., Otto M., Kreiswirth B.N., Chambers H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568.
9. Edwards B., Milne K., Lawes T., Cook I., Robb A., Gould I.M. Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010. J Clin Microbiol 2012, 50:318-325.
10. Gilot P., Lina G., Cochard T., Poutrel B. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J Clin Microbiol 2002, 40:4060-4067.
11. Gould I.M. MRSA bacteraemia. Int J Antimicrob Agents 2007, 30(Suppl 1):S66-S70.
12. Harris S.R., Feil E.J., Holden M.T., Quail M.A., Nickerson E.K., Chantratita N., et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
13. Higuchi W., Takano T., Teng L.J., Yamamoto T. Structure and specific detection of staphylococcal cassette chromosome mec type VII. Biochem Biophys Res Commun 2008, 377:752-756.
14. Hsueh P.R., Chen W.H., Teng L.J., Luh K.T. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005, 26:43-49.
15. Huang Y.C., Chen C.J. Community-associated meticillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. Int J Antimicrob Agents 2011, 38:2-8.
16. Jevons M.P., Coe A.W., Parker M.T. Methicillin resistance in staphylococci. Lancet 1693, 1:904-907.
17. Kallen A.J., Mu Y., Bulens S., Reingold A., Petit S., Gershman K., et al. MRSA Investigators of the Emerging Infections Program. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010, 304:641-648.
18. Kehrmann J., Kaase M., Szabados F., Gatermann S.G., Buer J., Rath P.M., et al. Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?. Eur J Clin Microbiol Infect Dis 2011, 30:677-683.
19. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
20. Kondo Y., Ito T., Ma X.X., Watanabe S., Kreiswirth B.N., Etienne J., et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother 2007, 51:264-274.
21. Liao C.H., Chen S.Y., Chang S.C., Hsueh P.R., Hung C.C., Chen Y.C. Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital. Diagn Microbiol Infect Dis 2005, 53:85-92.
22. Lodise T.P., Gotfried M., Barriere S., Drusano G.L. Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation. Antimicrob Agents Chemother 2008, 52:2300-2304.
23. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
24. Lu P.L., Tsai J.C., Chiu Y.W., Chang F.Y., Chen Y.W., Hsiao C.F., et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008, 23:1659-1665.
25. Ludwig F., Edwards B., Lawes T., Gould I.M. Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2012, 50:3383-3387.
26. Maree C.L., Daum R.S., Boyle-Vavra S., Matayoshi K., Miller L.G. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007, 13:236-242.
27. Moise-Broder P.A., Sakoulas G., Eliopoulos G.M., Schentag J.J., Forrest A., Moellering R.C. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis 2004, 38:1700-1705.
28. Okuma K., Iwakawa K., Turnidge J.D., Grubb W.B., Bell J.M., O'Brien F.G., et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002, 40:4289-4294.
29. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 2012, 81:143-148.
30. Prakash V., Lewis J.S., Jorgensen J.H. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 2008, 52:4528.
31. Sader H.S., Fey P.D., Limaye A.P., Madinger N., Pankey G., Rahal J., et al. Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother 2009, 53:4127-4132.
32. Sakoulas G., Eliopoulos G.M., Moellering R.C., Wennersten C., Venkataraman L., Novick R.P., et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002, 46:1492-1502.
33. Senna J.P., Pinto C.A., Carvalho L.P., Santos D.S. Comparison of pulsed-field gel electrophoresis and PCR analysis of polymorphisms on the mec hypervariable region for typing methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2002, 40:2254-2256.
34. Seybold U., Kourbatova E.V., Johnson J.G., Halvosa S.J., Wang Y.F., King M.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.
35. Steinkraus G., White R., Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007, 60:788-794.
36. Tenover F.C., Moellering R.C. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007, 44:1208-1215.
37. Tseng S.H., Lee C.M., Lin T.Y., Chang S.C., Chang F.Y. Emergence and spread of multi-drug resistant organisms: think globally and act locally. J Microbiol Immunol Infect 2011, 44:157-165.
38. Udo E.E., Pearman J.W., Grubb W.B. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993, 25:97-108.
39. Vaudaux P., Huggler E., Bernard L., Ferry T., Renzoni A., Lew D.P. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2010, 54:3861-3870.
40. Wang J.L., Tseng S.P., Hsueh P.R., Hiramatsu K. Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan. Emerg Infect Dis 2004, 10:1702-1704.
41. Wang J.T., Liao C.H., Fang C.T., Chie W.C., Lai M.S., Lauderdale T.L., et al. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 2009, 47:2957-2963.
42. Wang J.L., Wang J.T., Sheng W.H., Chen Y.C., Chang S.C. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method. BMC Infect Dis 2010, 10:159.
43. Wang W.Y., Chiueh T.S., Sun J.R., Tsao S.M., Lu J.J. Molecular typing and phenotype characterization of methicillin-resistant Staphylococcus aureus isolates from blood in Taiwan. PLoS One 2012, 7:e30394.